Related Experiment Video
Updated: Jun 1, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Activated human platelet products induce proarrhythmic effects in ventricular myocytes
Jonas S S G de Jong1, Arie O Verkerk, Marcel M G J van Borren
1Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Activated platelet products prolong cardiac action potentials and disrupt calcium handling, potentially triggering fatal arrhythmias during heart attacks. This research uncovers a key mechanism in sudden cardiac death.
Area of Science:
- Cardiovascular Physiology
- Cardiac Electrophysiology
- Platelet Biology
Background:
- Sudden cardiac death, often due to ventricular fibrillation (VF) during ischemia, is a major cause of mortality.
- Platelet activation is implicated in increasing VF susceptibility in ischemic heart tissue, but the underlying mechanisms are unclear.
Purpose of the Study:
- To investigate the effects of activated blood platelet products (ABPPs) on cardiac electrophysiology and intracellular calcium (Ca(2+)(i)) homeostasis.
- To elucidate the cellular mechanisms by which ABPPs may contribute to arrhythmias in ischemic conditions.
Main Methods:
- Human platelets were activated, and secreted products (ABPPs) were applied to isolated rabbit ventricular myocytes.
- Electrophysiological properties (membrane potential) and Ca(2+)(i) transients were measured using patch-clamp and indo-1 fluorescence.
- Specific ion channel currents, including L-type Ca(2+) current (I(Ca,L)), were analyzed.
Main Results:
- ABPPs prolonged action potential duration and induced early and delayed afterdepolarizations.
- ABPPs significantly increased I(Ca,L) density and enhanced systolic Ca(2+)(i), Ca(2+)(i) transient amplitude, and sarcoplasmic reticulum Ca(2+) content.
- Other major ion currents and Na(+)-Ca(2+) exchange current remained unaffected.
Conclusions:
- Secreted products from activated human platelets alter cardiac electrophysiology by modulating I(Ca,L) and Ca(2+)(i) homeostasis.
- These alterations lead to action potential prolongation and afterdepolarizations, which may promote reentrant arrhythmias in scenarios like coronary thrombosis.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...

